HOLLISTON, Mass., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for its fourth quarter and year ended December 31, 2010 before market trading hours on Friday, February 25, 2011.
